Hence, the current investigation has highlighted new knowledge of sivelestat as potent MMP-2, MMP-9, chikungunya nsP2 protease, and influenza neuraminidase inhibition activities, which help in the management of inflammation and viral infection-associated diseases. This evidence concerns the gene MMP9 and influenza.